Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 11/2025

Content (13 Articles)

The Road to Remyelination in Multiple Sclerosis: Breakthroughs, Challenges, and Considerations for Future Trial Design

  • Open Access
  • Current Opinion

Leah Zuroff, Vista Farkhondeh, Riley Bove, Ari J. Green

Advances in Pharmacotherapy for Menopausal Vasomotor Symptoms

  • Open Access
  • Review Article

Stephanie Young Moss, Angie Lee, James A. Simon

Systemic Therapy for Advanced Thyroid Cancer—New Personalized Options

Leslie Cheng, Kate Newbold

Current and Emerging Pharmacological Approaches to Agitation in Alzheimer’s Disease: A Narrative Review of New and Repurposed Therapies

Charles Smoller, Emily Schiller, Kyla Yamashita, Bret David Silverglate, George Thomas Grossberg

Pharmacological Therapies in Paroxysmal Nocturnal Haemoglobinuria: Focus on Complement Inhibition

Richard J. Kelly, Matthew Holt, Jeff Szer

Aldosterone Synthase Inhibitors for Resistant Hypertension: Pharmacological Insights – A Systematic Review

Arrigo F. G. Cicero, Giuliano Tocci, Ashot Avagimyan, Peter Penson, Giulia Nardoianni, Francesco Perone, Claudio Borghi, Federica Fogacci

Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer’s Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial

Susan Abushakra, Aidan Power, David Watson, Anton Porsteinsson, Marwan Sabbagh, Emer MacSweeney, Sharon Cohen, Mercè Boada Rovira, P. Murali Doraiswamy, Earvin Liang, Susan Flint, J. Patrick Kesslak, Rosalind McLaine, Adem Albayrak, Jean Schaefer, Jeremy Yu, Luke Tolar, Sam Dickson, John A. Hey, Martin Tolar

Senaparib: First Approval

Arnold Lee

Gepotidacin: First Approval

Susan J. Keam

Clesrovimab: First Approval

Yahiya Y. Syed

Fosrolapitant/Palonosetron: First Approval

Simon Fung

Sebetralstat: First Approval

Hannah A. Blair

Correction: Senaparib: First Approval

  • Correction

Arnold Lee

Oct 25
Issue: 10/2025
Dec 25
Issue: 12/2025

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more